Clinical analysis of 94 cases of ocular adnexal lymphomas by Yu‐ying Sun, Shu‐ai Luo, Chun‐yu Huang

“…CT and MRI can show the involvement and extent of the lesions, and the pathology of the disease is characterized by mucosa‐associated lymphoid tissue marginal zone B‐cell lymphoma (72/94), diffuse large B‐cell lymphoma (10/94), T‐cell lymphoma (4/94), mantle cell lymphoma (2/94), Burkitt's lymphoma (2/94), small lymphocytic lymphoma (2/94), and follicular lymphoma (1/94). …”
Get full text

Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein–Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor Growth by Krzysztof Wojtak, Alfredo Perales-Puchalt, David B. Weiner

“…Acute EBV infection can present as infectious mononucleosis, and lead to the future onset of multiple cancers, including Burkitt lymphoma, Hodgkin lymphoma, nasopharyngeal carcinoma, and gastric carcinoma. …”
Get full text

Epstein-Barr Virus Enhances Cancer-Specific Aberrant Splicing of TSG101 Pre-mRNA by Huey-Huey Chua, Toshiki Kameyama, Akila Mayeda, Te-Huei Yeh

“…Epstein-Barr virus (EBV) participates in a number of cancers, as reported mostly in nasopharyngeal carcinoma (NPC) and Burkitt lymphoma (BL). Using RT-nested-PCR and Northern blot analysis in NPC and BL cells, here we demonstrate that EBV promotes specific alternative splicing of TSG101 pre-mRNA, which generates the TSG101∆154-1054 variant though the agency of its viral proteins, such as EBNA-1, Zta and Rta. …”
Get full text

Hemin treatment drives viral reactivation and plasma cell differentiation of EBV latently infected B cells. by Anna M Burnet, Tonya Brunetti, Rosemary Rochford

“…Epstein-Barr virus (EBV) and Plasmodium falciparum have a well described role in the development of endemic Burkitt lymphoma (BL), yet the mechanisms involved remain unknown. …”
Get full text

Linfoma não-Hodgkin em crianças com imunodeficiência: relato de cinco casos Non-Hodgkin's lymphoma in children with immunodeficiency: report of five cases by Maria Christina L. A. Oliveira, Adriana R. Rodrigues, Keyla C. Sampaio, Ana Cecília S. C. Gomes, Marcos B. Viana

“…According to the REAL classification, two patients had precursor B-lymphoblastic lymphomas, one had an anaplastic large cell lymphoma, one had a peripheral B-cell neoplasm suggestive of Burkitt's lymphoma, and one had precursor T-lymphoblastic lymphoma. …”
Get full text

Management of Aggressive Non-Hodgkin Lymphomas in the Pediatric, Adolescent, and Young Adult Population: An Adult vs. Pediatric Perspective by Irtiza N. Sheikh, Amr Elgehiny, Dristhi Ragoonanan, Kris M. Mahadeo, Yago Nieto, Sajad Khazal

“…However, relapsed/refractory (R/R) disease is associated with poorer outcomes in many types of NHL such as diffuse large B cell lymphoma and Burkitt lymphoma. Newer therapies have been approved in the use of primary NHL in the pediatric and adolescent population such as Rituximab and other therapies such as chimeric antigen receptor T-cell (CAR T-cell) therapy are under investigation for the treatment of R/R NHL. …”
Get full text

MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs by C David Wood, Hildegonda Veenstra, Sarika Khasnis, Andrea Gunnell, Helen M Webb, Claire Shannon-Lowe, Simon Andrews, Cameron S Osborne, Michelle J West

“…EBV-driven MYC enhancer activation may contribute to the genesis and localisation of MYC-Immunoglobulin translocation breakpoints in Burkitt's lymphoma.…”
Get full text

The HLA-A,B,C genotype of the class I negative cell line Daudi reveals novel HLA-A and -B alleles. by Browning, M, Madrigal, J, Krausa, P, Kowalski, H, Allsopp, C, Little, A, Turner, S, Adams, E, Arnett, K, Bodmer, W

“…Daudi, a lymphoblastoid B cell line derived from an African Burkitt lymphoma does not express HLA-A,B,C antigens at the cell surface. …”

Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphoma. by Kung-Chao Chang, Wei-Chao Chang, Yao Chang, Liang-Yi Hung, Chien-Hsien Lai, Yu-Min Yeh, Yu-Wei Chou, Chung-Hsuan Chen

“…RanGAP1 was also highly expressed in other B-cell lymphomas (BCL, n = 180) with brisk mitotic activity (B-lymphoblastic lymphoma/leukemia: 93%, and Burkitt lymphoma: 95%) or cell-cycle dysregulation (mantle cell lymphoma: 83%, and Hodgkin's lymphoma 91%). …”
Get full text

Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells. by Jillian A Bristol, Joshua Brand, Makoto Ohashi, Mark R Eichelberg, Alejandro Casco, Scott E Nelson, Mitchell Hayes, James C Romero-Masters, Dana C Baiu, Jenny E Gumperz, Eric C Johannsen, Huy Q Dinh, Shannon C Kenney

“…Knock-down of IRF4 in a T1 LCL (infected with the Zp-V3-containing Akata strain) induced lytic reactivation whereas over-expression of IRF4 in Burkitt lymphoma cells inhibited both NFATc1 and NFATc2 expression and lytic EBV reactivation. …”
Get full text

Epstein–Barr Virus Latent Membrane Protein 2A (LMP2A) Enhances ATP Production in B Cell Tumors through mTOR and HIF-1α by Ryan Incrocci, Rosalinda Monroy Del Toro, Grace Devitt, Melody Salimian, Kamaljit Braich, Michelle Swanson-Mungerson

“…Our data indicate that LMP2A increases ATP generation in multiple Burkitt lymphoma cell lines that were dependent on HIF-1α. …”
Get full text

Induction of CYP3A activity by dexamethasone may not be strong, even at high doses: insights from a case of tacrolimus co-administration by Yoshiyuki Ohno, Toyohito Oriyama, Akira Honda, Mineo Kurokawa, Tappei Takada

“…The patient was diagnosed with post-transplant lymphoproliferative disease (histological type: Burkitt's lymphoma) after admission. Thereafter, the patient received cyclophosphamide-prednisolone (CP), followed by two courses of R-HyperCVAD (rituximab, cyclophosphamide, doxorubicin, vincristine, and DEX) and R-MA (rituximab, methotrexate, and cytarabine) replacement therapy. …”
Get full text

<i>CHEK2</i> Alterations in Pediatric Malignancy: A Single-Institution Experience by Eman Abdelghani, Kathleen M. Schieffer, Catherine E. Cottrell, Anthony Audino, Kristin Zajo, Nilay Shah

“…Results: We identified 6 patients with germline <i>CHEK2</i> variants from a cohort of 300 individuals, including 1 patient with concurrent presentation of Burkitt lymphoma and neuroblastoma, 3 patients with brain tumors, 1 patient with Ewing sarcoma, and 1 patient with myelodysplastic syndrome. …”
Get full text

The Enhanced Cytotoxic Effects in B-Cell Leukemia and Lymphoma Following Activation of Prostaglandin EP4 Receptor and Targeting of CD20 Antigen by Monoclonal Antibodies by Tijana Markovič, Helena Podgornik, Damjan Avsec, Sanja Nabergoj, Irena Mlinarič-Raščan

“…Herein, we report that EP4 receptor agonists PgE1-OH and L-902688 have exhibited enhanced cytotoxicity when applied together with anti-CD20 MAbs rituximab, ofatumumab and obinutuzumab in vitro in Burkitt lymphoma cells Ramos, as well as in p53-deficient chronic lymphocytic leukemia (CLL) cells MEC-1. …”
Get full text

دراسة انتشار لمفوما الجهاز الهضمي حسب النمط النسيجي ومقارنة نتائج العلاج لكل منها عند عينة من مرضى البيروني الجامعي... by Assef Diop

“…النتائج : شارك في الدراسة 62 مريض لمفوما جهاز هضمي منهم 58% ذكر  و 42% أنثى توزعت الإصابات بحسب النمط النسيجي ( التشريح المرضي ) كالتالي :Low grade MALT Lymphoma (61.3 %) - High Grade DLBCL (25.8 %) - Burkitt's Lymphoma (4.8 %) - Mantle Lymphoma (3.2 %) - Lymphoblastic Lymphoma (3.2 %) - Peripheral T-Cell Lymphoma (EATL) (1.6 %) . …”
Get full text

Performance of Positron Emission Tomography-Computed Tomography and Bone Marrow Biopsy in Detecting Bone Marrow Infiltration in Lymphoma Cases by Mahmut Büyükşimşek, İrem Kolsuz, Abdullah Evren Yetişir, Mert Tohumcuoğlu, Ali Oğul, Cem Mirili, Semra Paydaş, İsa Burak Güney

“…PET/CT performance for diffuse large B-cell lymphoma and follicular lymphoma was better than that of BMB, whereas the performance of BMB was better for mantlecell lymphoma, Burkitt's lymphoma, and primary mediastinal B-cell lymphoma. …”
Get full text

دراسة انتشار لمفوما الجهاز الهضمي حسب النمط النسيجي ومقارنة نتائج العلاج لكل منها عند عينة من مرضى البيروني الجامعي... by آصف ديوب

“…النتائج : شارك في الدراسة 62 مريض لمفوما جهاز هضمي منهم 58% ذكر  و 42% أنثى توزعت الإصابات بحسب النمط النسيجي ( التشريح المرضي ) كالتالي :Low grade MALT Lymphoma (61.3 %) - High Grade DLBCL (25.8 %) - Burkitt's Lymphoma (4.8 %) - Mantle Lymphoma (3.2 %) - Lymphoblastic Lymphoma (3.2 %) - Peripheral T-Cell Lymphoma (EATL) (1.6 %) . …”
Get full text

Selektivitas antikanker ekstrak kasar dan fraksi kolom biji Momordica charantia L. terhadap Sel Raji, HeLa dan T47D by Perpustakaan UGM, i-lib

“…Some cancer cells like Raji cell line and HeLa cell line are derived from Burkitt's lymphoma and cervical carcinoma, respectively. …”

Broadening the horizon: potential applications of CAR-T cells beyond current indications by Hendrik Karsten, Ludwig Matrisch, Ludwig Matrisch, Sophia Cichutek, Walter Fiedler, Winfried Alsdorf, Andreas Block

“…We focus on B- and T-cell malignancies, including the entities of cutaneous and peripheral T-cell lymphoma (T-ALL, PTCL, CTCL), acute myeloid leukemia (AML), chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), classical Hodgkin-Lymphoma (HL), Burkitt-Lymphoma (BL), hairy cell leukemia (HCL), and Waldenström’s macroglobulinemia (WM). …”
Get full text

Mechanism of action of triclosan as an endocrine-disrupting chemical with its impact on human health – literature review by Marcela Maksymowicz, Piotr Artur Machowiec, Gabriela Ręka, Anna Korzeniowska, Patryk Leszczyk, Halina Piecewicz-Szczęsna

“…On the other hand, it contributes to apoptosis in Burkitt lymphoma-derived cells, which means that TCS can have antitumour properties. …”
Get full text